FdaApplication
ANDA 215453
Identifiers
- fda_app_no: ANDA215453
Properties
| Property | Value |
|---|---|
| applicant_name | COREPHARMA LLC |
| application_type | ANDA |
| approval_date | 2022-07-29 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE | 5MG;2.5MG | CAPSULE;ORAL |
1 product